Overview

Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis

Status:
Completed

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

The study will be conducted to evaluate the efficacy and safety of a topical dimeticone formulation (Loion®) compared to 10% salicylic acid in octyl-dodecanol with 15% Macrogol-4-laurylether for the removal of scaling in patients with chronic psoriasis capitis (scalp psoriasis).

Phase:

Phase 2

Details

Lead Sponsor:

G. Pohl-Boskamp GmbH & Co. KG

Collaborator:

Universitätsklinikum Hamburg-Eppendorf

Treatments:

Salicylates
Salicylic Acid